120
Participants
Start Date
February 23, 2023
Primary Completion Date
March 31, 2027
Study Completion Date
March 31, 2027
Haploidentical stem cell transplantation
Stem cell transplant from bone marrow or peripheral blood from haploidentical donor using standard nationally approved transplant procedure.
Standard medical care
Standard medical care may include any currently available therapies for SCD patients. These may or may not include regular elective transfusion therapy or medications such as hydroxycarbamide.
RECRUITING
King's College Hospital, London
King's College London
OTHER
University of Sheffield
OTHER
Sheffield Teaching Hospitals NHS Foundation Trust
OTHER
Imperial College Healthcare NHS Trust
OTHER
Guy's and St Thomas' NHS Foundation Trust
OTHER
University College London Hospitals
OTHER
Manchester University NHS Foundation Trust
OTHER_GOV
St George's University Hospitals NHS Foundation Trust
OTHER
Barts & The London NHS Trust
OTHER
National Institute for Health Research, United Kingdom
OTHER_GOV
King's College Hospital NHS Trust
OTHER